Clinical trials
Observational Metabolic Diseases trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 2 |
| Completed | 2 |
| Terminated | 2 |
| Unknown status | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Calcilytix Therapeutics, Inc., a BridgeBio company | 1 |
| HemoShear Therapeutics | 1 |
| Laval University | 1 |
| REGENXBIO Inc. | 1 |
| Shire | 1 |
| Sumitomo Pharma Switzerland GmbH | 1 |
| University of Manitoba | 1 |
| University of Toronto | 1 |
| Université de Sherbrooke | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Diseases | 9 |
| Genetic Diseases, Inborn | 4 |
| Cardiovascular Diseases | 3 |
| Lipid Metabolism Disorders | 3 |
| Metabolism, Inborn Errors | 3 |
| Brain Diseases | 2 |
| Brain Diseases, Metabolic, Inborn | 2 |
| Central Nervous System Diseases | 2 |
| Lysosomal Storage Diseases | 2 |
| Musculoskeletal Diseases | 2 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.